AGN : Analysis & Opinions

  • Showing 1-100 of 103 items
  • 1
  • 2
  • >>
  1. In This Case Silence Could be Golden

    January 17, 2017
    Healthcare stocks are falling again ahead of Friday's transition of power.
  2. AGN Falls Despite Positive Trial Results

    January 17, 2017
    Allergan's shares are falling about two percent to start the day despite positive Phase III trial results.
  3. Healthcare Slammed As Trump Vows To Fight Drug Prices

    January 11, 2017
    Today President-Elect Trump once again stated he wants to take on drug pricing.
  4. Addison Capital Co Buys Stericycle Inc, PayPal Holdings Inc, ...

    January 11, 2017
    Philadelphia, PA, based Investment company Addison Capital Co buys Stericycle Inc, PayPal Holdings Inc, KeyCorp, Fortis Inc, ...
  5. North Star Asset Management Inc Buys Hanesbrands Inc, Allergan ...

    January 11, 2017
    Menasha, WI, based Investment company North Star Asset Management Inc buys Hanesbrands Inc, Allergan PLC, First Data Corp, ...
  6. AGN Makes Two Small Deals

    January 9, 2017
    AGN announced two small deals on Monday morning. However, its stock price faces a technical wall of worry.
  7. Drug Price Debate May Lead to Smaller Price Hikes

    January 5, 2017
    Some drug makers have capped drug price increases to single digits in 2017 amid public outcry.
  8. Allergan Is Playing Its Cards Close To The Vest

    January 5, 2017
    Allergan gave a preview of its full year 2017 EPS and revenue guidance.
  9. Health Care Stocks With Short-term Upside (AGN)

    January 4, 2017
    While these trades should be considered risky, recent strength indicates a potential short-term turnaround in these pharmaceutical ...
  10. Allergan Continues 2017 Where It Left Off In 2016

    January 3, 2017
    AGN shares rose more than 4% after the FDA approved its new breast implants.
  11. Healthcare Stocks Struggled in 2016

    December 30, 2016
    Healthcare stocks struggled all year. Things may be looking up in the new year.
  12. Bulls Are Pushing Allergan Shares Higher

    December 29, 2016
    Allergan is bucking the trend for the second day in a row, with shares up nearly 7% in the past week. The numbers for 2016 ...
  13. Shares of Allergan Showing Positive Momentum

    December 27, 2016
    The bulls on Wall Street are giving new life to pharmaceutical company Allergan.
  14. Allergan to Buy LifeCell For $2.9 Billion

    December 21, 2016
    Can this marriage, which includes regenerative medice tissue products, help grow the company?
  15. Allergan's Stock Price Can't Make Up Its Mind

    December 16, 2016
    A Goldman Sachs downgrade, and a settlement with the government, have AGN shares flip-flopping.
  16. Allergan Shares Are Up 4% After Analyst Comments

    December 9, 2016
    Shares of AGN are surging by 4% following comments out of Citi and Credit Suisse.
  17. Allergan Talks Strategy at Citi Conference

    December 8, 2016
    Brent Saunders, AGN's CEO had much to say about drug pricing and acquisition possibilities.
  18. Piper Jaffray Negative On Allergan (AGN)

    December 7, 2016
    Piper Jaffray issued a Negative report on AGN this morning noting the business is not likely to see a rebound.
  19. JP Morgan Positive on Allergan (AGN)

    December 5, 2016
    This morning AGN's rating and price target were reiterated at JP Morgan, which sees the stock a compelling opportunity.
  20. Amgen, Allergan File for Avastin Biosimilar in EU (AGN)

    December 5, 2016
    Amgen and Allergan are all set to grab a slice of billion-dollar cancer drug market with their ABP 215 biosimilar.
  21. Allergan & Amgen Looking for Approvals (AGN, AMGN)

    December 2, 2016
    Amgen and Allergan file in to get approval for Avastin biosimilar ABP 215 in Europe.
  22. Q3 Shows Hedge Funds Abandoning Healthcare Stocks (AGN, EBAY)

    November 29, 2016
    According to recent 13F reports, many of the top hedge funds in the country seemed to be turning away from the healthcare ...
  23. Dan Loeb's Third Point Bolsters Tech Positions (AAPL, BABA)

    November 29, 2016
    The billionaire hedge fund leader bought up stock in Apple, Alibaba and Facebook in Q3.
  24. Carl Icahn Nearly Exits Allergan Position in Q3 (AGN, HLF)

    November 29, 2016
    Icahn makes a big reversal on the embattled pharmaceuticals company, according to his Q3 13F.
  25. Many Billion-Dollar ‘Biobuck’ Drug Deals Go Bust

    November 28, 2016
    Despite the high-value deal announcements, a high percentage of biotech deals fail to meet milestones.
  26. Allergan Makes Yet Another Acquisition

    November 23, 2016
    Acquisitive pharmaceutical major Allergan (NYSE: AGN) is at it again: The drugmaker has opened its wallet for another in ...
  27. FDA Approves Allergan's Xen Glaucoma Stent (AGN)

    November 23, 2016
    Allergan is all set to reap the benefits of its $300 million buyout of AqueSys’ Xen glaucoma gel stent.
  28. Allergan Buys Alzheimer's Drug Maker for $125M (AGN)

    November 23, 2016
    Allergan purchased Chase Pharmaceuticals in a deal worth over $125 milllion.
  29. Sales of Allergan's Older Drugs Dwindle (AGN)

    November 20, 2016
    Sales of Allergan’s established drugs are falling in the face of new competition and pricing pressures.
  30. Amgen Files BLA for Avastin Biosimilar (AMGN, AGN)

    November 16, 2016
    Amgen leaps ahead with its biosimilars program, adding an Avastin copycat to its portfolio.
  31. Trump Victory A Step In The Right Direction: Carl Icahn

    November 9, 2016
    The latest bromance in town is between a billionaire investor and the President-elect.
  32. Bonuses on Wall Street to Take a Dive (DOW, PFE)

    November 7, 2016
    Poor fund returns and stalled mergers have caused bonuses on Wall Street to decline for the third year in a row.
  33. Allergan Initiates Dividend, Boosts Share Buybacks

    November 3, 2016
    Busy pharmaceutical player Allergan (NYSE: AGN) has taken on an additional burden -- it will start to pay a dividend to ...
  34. Allergan Expands Buyback to $15B, Begins Div (AGN)

    November 3, 2016
    Allergan initiated a quarterly dividend of 70 cents starting in March 2017, and expanded its stock buyback program from $1 ...
  35. Allergan Cuts Year Forecast: 3Q Below Street (AGN)

    November 2, 2016
    Allergan's 3Q earnings fell below analyst estimates, forcing it to reduce its fiscal year earnings projections.
  36. Opioid Makers Targeted in Lawsuits (JNJ, AGN)

    October 28, 2016
    Several states are suing opioid makers like Allergan and Johnson & Johnson, citing the alarming increase in painkiller addiction.
  37. Allergan to Acquire Biotech Firm for $200M (AGN)

    October 28, 2016
    Allergan agreed to acquire Motus Therapeutics, a Boston biopharmaceutical company, for over $200 million.
  38. What Has Alan Schwartz Done for Guggenheim?

    October 11, 2016
    The former Bear Stearns CEO has worked to transform Guggenheim Partners' reputation, developing an investment bank from scratch.
  39. Will Gilead Make a Good Fit for Allergan? (GILD)

    September 22, 2016
    Allergan made two recent acquisitions in the NASH diseases space, and Gilead’s strong NASH drug portfolio can fit well with ...
  40. Allergan Buys 2 Liver Disease-Focused Biopharmas

    September 21, 2016
    The big pharmaceutical company that loves to acquire smaller peers is at it again. Allergan (NYSE: AGN) announced that it ...
  41. Vitae Shares Zoom Higher on Sale to Allergan

    September 14, 2016
    Few events goose a stock price better than a buyout from a deep-pocketed suitor. Such is the case with Vitae Pharmaceuticals ...
  42. Defensive Investing: Learn from a Hedge Fund Pro

    August 31, 2016
    Looking for ideas on companies, sectors or investments to short? Consider the opinion of this hedge fund luminary.
  43. Breaking Down Baupost's Holdings for Q2 (LMCA, QVCA)

    August 25, 2016
    Seth Klarman's hedge fund revealed large stakes in energy companies and the Liberty media company group for the second quarter.
  44. Top 10 Stocks Hedge Funds Bought and Sold in Q2 (HOT, STJ)

    August 24, 2016
    The 13F filings reveal that these stocks saw the most activity across the hedge fund industry in the second quarter.
  45. Top 5 Shareholders of Allergan (AGN)

    August 24, 2016
    Discover the top institutional and direct Allergan shareholders. Learn about their shareholdings and associations with the ...
  46. Big Sell-Off of Pfizer Amid Merger Collapse (PFE, AGN)

    August 19, 2016
    The collapse of the planned merger of Pfizer and Allergan triggered major waves in stock holdings among the country's top ...
  47. Hedge Fund Confidence in Stocks Improves in Q2 (CHTR, MS)

    August 18, 2016
    After a sell-heavy Q1, leading hedge funds have shifted to a more confident approach to stocks, but there is still room to ...
  48. Allergan Features Prominently in Q2 2016 (AGN, PFE)

    August 17, 2016
    13F filings from top investors show that the pharmaceutical company was a big mover in Q2.
  49. New Icahn Filing Details Fresh Stake in Allergan

    August 16, 2016
    One of the market's most high-profile -- and notorious -- activist investors has revealed new stock holdings, and a number ...
  50. Tepper's Appaloosa Remains Cautious on S&P and Airlines, Focuses ...

    August 15, 2016
    Hedge fund manager David Tepper's investments in 2Q 2016 moved away from S&P 500 holdings and major airlines, favoring pharmaceuticals ...
  51. Allergan's Q2 Earnings Beat Boosted by Botox

    August 8, 2016
    With the failed Pfizer merger out of the way, Allergan appears focused and is looking once again to maximize growth in its ...
  52. Teva Expands Both Branded, Generics (TEVA, AGN)

    August 3, 2016
    Teva has purchased Allergan's generics business but will continue to focus on its specialized branded drugs.
  53. Jamie Zimmerman's Q1 Healthcare Stocks: AGN,GILD

    July 12, 2016
    Jamie Zimmerman of Litespeed Managmenet shifts her perspective on healthcare giants AGN and GILD in Q1.
  54. Billionaire John Paulson's Q1 Biotechs: AGN, SGYP

    June 23, 2016
    Let's take a look at billionaire hedge fund manager John Paulson's Q1 investments in these healthcare stocks: AGN, SGYP
  55. 3 Mutual Funds Poised to Perform in the Future (VGENX, FSPHX)

    June 19, 2016
    Learn about sector weightings in growth mutual funds versus the benchmark and how three funds are positioned to profit from ...
  56. Avoid Betting on These Acquisition Target Stocks (PFE, AGN)

    June 16, 2016
    Many target stocks high on acquirers list are trading at deep discounts. Here’s why investors should avoid them.
  57. Is Investment Banking Peaking? (PFE, AGN)

    June 15, 2016
    Learn about the numerous challenges facing investment banking and explore whether the industry is peaking.
  58. Biotech Stocks: Are They Back?

    June 1, 2016
    The bearish trends over the past year have started to reverse themselves which has benefted the biotech industry
  59. Allergan Stock Rises on Carl Icahn's Stake (AGN, PFE)

    June 1, 2016
    The Botox maker got a much-needed dose of confidence Tuesday when the market learned that activist investor Carl Icahn had ...
  60. Carl Icahn Acquires a Large Position in Allergan (AGN)

    May 31, 2016
    Carl Icahn has purchased a large position in Allergan, the maker of Botox, after its failed merger with Pfizer in April 2 ...
  61. 3 ETFs Affected by the Failed Pfizer-Allergan Merger (PFE, AGN)

    May 28, 2016
    Discover three ETFs that were affected by the failed Pfizer and Allergan acquisition, and learn about the performances and ...
  62. CF Industries Drops Planned Purchase of OCI

    May 24, 2016
    A federal crackdown on tax inversion mergers has effectively killed a planned acquisition by fertilizer maker CF Industries' ...
  63. Allergan Stock Falls to New Low Ahead of Earnings (AGN, PFE)

    May 9, 2016
    Wall Street expects the maker of cosmetic injection Botox to deliver year-over-year declines in both revenue and profits.
  64. Pfizer Stock Rises Ahead of Earnings (PFE, AGN)

    May 2, 2016
    It turns out Pfizer might not have needed Allergan after all, given that PFE shares have surged 9% and 7.3% in the respective ...
  65. 6 Reasons to Watch Kythera Biopharm Inc. (AGN, PFE)

    May 1, 2016
    Discover why the Russell 2000 and other investment indexes believe California-based Kythera Biopharmaceuticals Inc. is a ...
  66. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  67. (VRX) Who are Valeant's Main Competitors?

    April 23, 2016
    Learn which companies Valeant is likely watching closely, since it is known for acquiring companies for their products rather ...
  68. Singer Gets Better End of AGN-PFE Deal Implosion

    April 12, 2016
    Paul Singer increased his stake in Allergen by 204.75% in the fourth quarter. How will this impact his portfolio since the ...
  69. Pfizer CEO: Let Us Invest in the U.S. (AGN, PFE)

    April 7, 2016
    Ian Read, Chairman and CEO of Pfizer, published an op-ed in the Wall Street Journal Wednesday, in which he defended the logical ...
  70. Allergan's Fall Hits Hedge Funds Hard (AGN, PFE)

    April 6, 2016
    When shares in Allergan dropped 14.8% to $236.55 on Tuesday, not everyone realized how much – and how many – hedge funds ...
  71. Fidelity Capital & Income Fund's Top 5 Holdings Analysis (FAGIX)

    April 6, 2016
    Evaluate the top five holdings of the Fidelity Capital & Income Fund, and study the basics and recent performance of the ...
  72. Pfizer Withdraws Merger Bid With Allergan (AGN, PFE)

    April 6, 2016
    Pfizer has come to realize the U.S. Treasury Department's new stance with inversions: "Over my dead body."
  73. Allergan Now Trades Cheaper Than Its Standalone Value

    April 5, 2016
    Shibani Malhotra of Nomura thinks Allergan plc Ordinary Shares (NYSE: AGN) is compelling, despite treasury notice that threatens ...
  74. The Market In 5 Minutes: Tuesday, April 5, 2016

    April 5, 2016
    Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in ...
  75. Allergan Crushed as Tax Inversion Rules Threaten PFE Deal (AGN, ...

    April 5, 2016
    Given the army of lawyers, not to mention lobbyists, on their respective payrolls, Allergen and Pfizer are not likely to ...
  76. Portfolio Trends in 2016 (VGHCX)

    March 25, 2016
    Evaluate the composition of the Vanguard Health Care Fund, and study how the fund's makeup has evolved over the previous ...
  77. Portfolio Trends in 2016 (PRHSX)

    March 23, 2016
    Discover how the T. Rowe Price Health Sciences Fund is positioned in 2016, and learn what trends in the portfolio may help ...
  78. (XLV) Healthcare SPDR ETF: Top 5 Holdings

    March 18, 2016
    Discover the top five stocks in the Health Care Select Sector SPDR Fund, and learn if they can help power your portfolio ...
  79. The 5 Highest Paid Executives in the Healthcare Sector (AGN, ...

    March 18, 2016
    Discover who the highest paid executives in the health care sector are and how much they make, while the cost of health care ...
  80. Analyzing Actavis' Price & Profitability Ratios in 2016 (AGN)

    March 5, 2016
    Analyze several price ratios and profitability ratios to evaluate the specialty pharmaceutical company, Allergan PLC.
  81. Top 5 Positions in Janus Capital Management's Portfolio (JNS, ...

    February 29, 2016
    Explore detailed analyses of the top five positions in Janus Capital Management's portfolio based on the company's September ...
  82. Top 5 Positions in John Paulson's Portfolio (AGN, VRX)

    February 29, 2016
    Find out which stocks are holding the top five positions in investment guru John Paulson's hedge fund portfolio and which ...
  83. The Top 5 Positions in Barry Rosenstein's Portfolio (QCOM, HTZ)

    February 27, 2016
    Take a look at the top five holdings for billionaire investor Barry Rosenstein, founder of activist investment advisory fund ...
  84. Mind the GAAP: Buyer, Beware Profit 'Adjustment'

    February 25, 2016
    S&P 500 companies are reporting "adjusted" earnings that are much more enticing than their profits according to generally ...
  85. Allergan: An Activist Investment Analysis (AGN,VRX)

    January 28, 2016
    Read about the activist investor campaign against Allergan by Bill Ackman. See how Ackman partnered with another drug company ...
  86. How the New Allergan Plc Will Make Money

    January 14, 2016
    Allergan plc is not only enormous, it's about to more than double in size. Here's why and how.
  87. The Top 10 Healthcare Stocks for 2016 (ABT, AGN)

    January 6, 2016
    Learn about the top 10 health care stocks expected to grow in 2016, with brief insights into each company's growth potential ...
  88. 5 Big M&A deals in 2015 (PFE, AGN)

    December 23, 2015
    Learn how these mergers and acquisitions helped make 2015 a boom year for M&A deals, with the total value of the companies ...
  89. 3 Popular Healthcare Stocks in 2015 (CVS, AGN)

    December 23, 2015
    Discover the three most popular health care stocks of 2015, including an affordable stock that caught BlackRock Investment ...
  90. M&A Hits a Record in 2015

    December 4, 2015
    2015 has been a record year for mergers and acquisitions as M&A activity hit record levels, fuelled by consolidation in various ...
  91. Retail Investors May Face Capital Gains Tax on Pfizer Allergan ...

    November 30, 2015
    The Pfizer-Allergan merger may end up costing retail investors a pretty penny, but they may be able to minimize their losses. ...
  92. Why Are Pfizer And Allergan Talking About A Split Even Before ...

    November 24, 2015
    The proposed merger between Pfizer and Allergan might be headed towards a split in the future. Why?
  93. Positive GDP Number Increases Chance of Rate Hike

    November 24, 2015
    The chances for a December hike in interest rates became stronger this morning with an uptick in U.S. GDP numbers during ...
  94. Pfizer-Allergan Merger Makes Biggest Firm by Sales

    November 23, 2015
    On November 22, 2015, America’s Pfizer and Ireland’s Allergan received their board of directors’ approval to merge in what ...
  95. New Treasury Rules Won't Stop Corporate Inversions (PFE, AGN)

    November 20, 2015
    The US Treasury Department unveiled new rules to curb corporate inversions. But, they may not be enough.
  96. Pfizer and Allergan Talk Mammoth Healthcare Deal

    November 19, 2015
    Pharmaceutical giant Pfizer Inc. is in talks with Botox maker Allergan Plc, to buy the latter in a deal worth $150 billion.
  97. Pfizer - Allergan: Will This Deal Happen? (PFE, AGN)

    October 30, 2015
    The question for investors is: Will this deal happen?
  98. Target Fires First Shot in Holiday Wars at Wal-Mart

    October 30, 2015
    In a move that has threatened retail giant WalMart (WMT), Target (TGT) has announced that it will offer free shipping and ...
  99. Teva Pharma to Acquire Allergan: Analysts Weigh In

    July 28, 2015
    Teva Pharmaceutical announced a definitive agreement to buy Allergan Inc. for $40.5 billion. What analysts are saying?
  100. Will These High-Flying Stocks Stay Hot in 2015?

    May 22, 2015
    These 10 stocks were on fire in 2014. Will they stay hot?
  • Showing 1-100 of 103 items
  • 1
  • 2
  • >>